Top compounds associated with response to LYPD1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0048 0.9
mRNA XMD13-2 GDSC1000 pan-cancer AAC -0.0039 0.9
mRNA lapatinib CTRPv2 pan-cancer AAC 0.0047 0.9
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.0062 0.9
mRNA CGP-60474 GDSC1000 pan-cancer AAC -0.0066 0.9
mRNA methylstat CTRPv2 pan-cancer AAC -0.005 0.9
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0043 0.9
mRNA cediranib CTRPv2 pan-cancer AAC 0.0061 0.9
mRNA AT-406 CTRPv2 pan-cancer AAC 0.0053 0.9
mRNA canertinib CTRPv2 pan-cancer AAC 0.0039 0.9
Download CSV